In an industry fraught with constant challenges, medtech leaders need to close the growing skills gap of their employee base and develop leadership from within. The pandemic’s impact on an increasingly remote workforce has caused companies to adopt a new approach to cultivating emerging leaders.
Data integration is doing much to enhance regulatory information management. Life sciences companies are increasingly discovering useful interdependencies between data, documents and RIM processes. The next step is to put this data to work to improve efficiency.
Regardless of the reason for disposing of a medical device or other electronic equipment, the product must be destroyed in a manner in which it can never be reused or identified as coming from your organization. In addition, the resulting materials from the destruction process be disposed of in an environmentally appropriate and regulatory compliant manner.
Its success lies in a synergy between the technological and the clinical.
Incorporating bioinformatics platforms can ease the burden of tracking, analyzing and managing the use of antibiotics.
Regenerative medicine unites doctors, scientists, engineers, and others to accelerate healing processes.
The challenge for the digital health community will be to bring the same high standards for care in the physical world to their digital interactions.
Moving too quickly in the product development process can lead to mistakes.
Part three of this series discusses the key defenses available to each element of a lawsuit against providers and labs.
The pandemic is helping realize the potential of ISO IDMP data standards in relation to adverse event reporting, electronic prescribing and medicines control in the supply chain.